Shared genetics may shape treatment options for certain brain disorders

June 20, 2018 by Bill Snyder, Vanderbilt University
Bipolar disorder is characterized by transitions between depression and mania. Credit: Wikipedia

Symptoms of schizophrenia and bipolar disorder, including psychosis, depression and manic behavior, have both shared and distinguishing genetic factors, an international consortium led by researchers from Vanderbilt University and Virginia Commonwealth University is reporting.

The consortium's findings, which were published online June 14 in the journal Cell, are raising hopes that genetics could help characterize and eventually inform more effective treatment options for patients with these brain disorders.

"We can show that some of these symptoms which comprise these diagnoses have underlying biology that can be studied separately and characterized," said first author Douglas Ruderfer, Ph.D., assistant professor of Medicine, Psychiatry and Behavioral Sciences, and Biomedical Informatics in the Vanderbilt University School of Medicine.

"Of the many interesting findings reported here, one of the most important has been our ability to classify the risk genes for schizophrenia and into three broad groups: those that influence risk for both disorders about equally, those that impact only on risk for schizophrenia with no apparent effect on bipolar illness and the smaller group that appear to act only specifically on bipolar illness," said senior author Kenneth Kendler, MD, director of the Virginia Institute for Psychiatric and Behavioral Genetics at VCU.

Schizophrenia and bipolar disorder are among the world's leading causes of disability. Although they are clinically distinct entities, they are often both seen within the same families and share overlapping symptoms.

With the sequencing of the human genome and development of powerful computational tools, it became possible to look for genetic variants that explain the biological basis for the differences between these two brain disorders—and their common symptoms.

The problem was numbers, said Ruderfer, an investigator in the Vanderbilt Genetics Institute who came to Vanderbilt in 2016 from the Icahn School of Medicine at Mount Sinai in New York City. Researchers needed to study thousands of patients in order to tease out "needles" from their genetic "haystacks."

Toward that end Kendler and another pioneer in psychiatric genetics—the late Pamela Sklar, MD, Ph.D.—along with a number of other investigators including especially Patrick Sullivan helped organize the Psychiatric Genomics Consortium. In 2014, they, Ruderfer and their colleagues, published the first evidence that differences between bipolar disorder and schizophrenia have a genetic basis.

The current study, authored by the consortium's Bipolar Disorder and Schizophrenia Working Group, involved more than 500 investigators at more than 200 institutions in 34 countries.

Pooling their resources, the researchers were able to accumulate more than 53,000 individuals diagnosed with bipolar disorder or schizophrenia and substantial information on 28 symptoms of these disorders.

The researchers compared genotypes, the genetic readout, of individuals with the to those from 54,000 controls who did not have either mental illness. They also compared the genotypes of people who had differing symptoms of bipolar disorder or schizophrenia.

The analysis, called a genome-wide association study, identified dozens of loci, or chromosomal locations, that were shared, and multiple loci that were divergent between bipolar disorder and schizophrenia. The researchers were able to quantify genetic risk of each disorder in each individual and correlate the genetic component with the symptoms.

Some of these genetic components clearly distinguished between the two illnesses, while others, particularly those that were associated with psychosis, were shared. In other words, people who experienced psychotic symptoms had similar genetic traits—whether they had been diagnosed with bipolar disorder or .

More research is needed. But "if we could utilize genetics as a kind of biomarker, (potentially) we could inform treatment and tie that to outcome and course of illness," Ruderfer said.

Explore further: Shared genetics in schizophrenia and bipolar disorder

More information: Douglas M. Ruderfer et al. Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes, Cell (2018). DOI: 10.1016/j.cell.2018.05.046

Related Stories

Shared genetics in schizophrenia and bipolar disorder

October 2, 2017
A genetic variant associated with multiple psychiatric disorders drives changes in a brain network that may increase an individual's risk of developing bipolar disorder and schizophrenia, finds a study published in Journal ...

Family study emphasizes distinct origins for bipolar disorder subtypes

January 10, 2018
The most common subtypes of bipolar disorder, bipolar I and bipolar II, stem—at least in part—from different biological causes, according to a new study published in Biological Psychiatry. Despite genetic overlap between ...

Gene breakthrough on lithium treatment for bipolar disorder

November 8, 2017
Genes linked to schizophrenia in psychiatric patients suffering from bipolar disorder are the reason why such patients don't respond to the "gold standard" treatment for bipolar - the drug lithium - according to international ...

Replicating risk genes in bipolar disorder

October 15, 2012
One of the biggest challenges in psychiatric genetics has been to replicate findings across large studies.

'Schizophrenia' does not exist, argues expert

February 2, 2016
The term "schizophrenia," with its connotation of hopeless chronic brain disease, should be dropped and replaced with something like "psychosis spectrum syndrome," argues a professor of psychiatry in The BMJ today.

Study sheds light on genetic overlap between major psychiatric disorders

February 8, 2018
Most medical disorders have well-defined physical characteristics seen in tissues, organs and bodily fluids. Psychiatric disorders, in contrast, are not defined by such pathology, but rather by behavior.

Recommended for you

Test could detect patients at risk from lethal fungal spores

September 20, 2018
Scientists at The University of Manchester have discovered a genetic mutation in humans linked to a 17-fold increase in the amount of dangerous fungal spores in the lungs.

Researchers identify a new cause of childhood mitochondrial disease

September 20, 2018
A rapid genetic test developed by Newcastle researchers has identified the first patients with inherited mutations in a new disease gene.

Why some human genes are more popular with researchers than others

September 18, 2018
Historical bias is a key reason why biomedical researchers continue to study the same 10 percent of all human genes while ignoring many genes known to play roles in disease, according to a study publishing September 18 in ...

Class of neurological disorders share 3-D genome folding pattern, study finds

September 18, 2018
In a class of roughly 30 neurological disorders that includes ALS, Huntington's Disease and Fragile X Syndrome, the relevant mutant gene features sections of repeating base pair sequences known as short tandem repeats, or ...

Researchers resolve decades-old mystery about the most commonly mutated gene in cancer

September 18, 2018
The most commonly mutated gene in cancer has tantalized scientists for decades about the message of its mutations. Although mutations can occur at more than 1,100 sites within the TP53 gene, they arise with greatest frequency ...

Study of one million people leads to world's biggest advance in blood pressure genetics

September 17, 2018
Over 500 new gene regions that influence people's blood pressure have been discovered in the largest global genetic study of blood pressure to date, led by Queen Mary University of London and Imperial College London.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.